Sign in

CIK 0001790340

  • Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$89,500
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gengos Andrew +$90K Chief Financial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-02-10 Zeskind Benjamin J. PRESIDENT AND CEO Grant or award · Stock Option +45,615 202,100
2022-01-14 HAUSMAN DIANA Director Grant or award · Stock Option +25,200 $13.00 $328K 25,200
2021-12-22 Hall Brett Matthew CHIEF SCIENTIFIC OFFICER Grant or award +322,691 329,084
2021-09-20 Feinberg Peter Director Purchase +4,750 $24.45 $116K 5,099
2021-09-13 Feinberg Peter Director Purchase +5,750 $21.51 $124K 392,242
2021-09-13 Feinberg Peter Director Purchase +349 $21.25 $7K 349
2021-09-13 Zeskind Benjamin J. PRESIDENT AND CEO Purchase +2,083 $22.87 $48K 2,602,352
2021-08-03 Cormorant Asset Management, LP Former 10% Owner Conversion +1,702,628 1,702,628
2021-08-03 Cormorant Asset Management, LP Former 10% Owner Purchase +550,000 $15.00 $8.3M 2,252,628
2021-08-03 Cormorant Asset Management, LP Former 10% Owner Conversion · Series B Convertible Preferred Stock −1,702,628 0
2021-08-03 Feinberg Peter Director Conversion +133,572 257,325
2021-08-03 Feinberg Peter Director Purchase +129,167 $15.00 $1.9M 386,492
2021-08-03 Feinberg Peter Director Conversion +123,155 347,401
2021-08-03 Feinberg Peter Director Purchase +129,167 $15.00 $1.9M 476,568
2021-08-03 Feinberg Peter Director Conversion +82,108 82,108
2021-08-03 Feinberg Peter Director Purchase +33,333 $15.00 $500K 115,441
2021-08-03 Feinberg Peter Director Conversion · Series A Preferred Stock −102,926 0
2021-08-03 Feinberg Peter Director Conversion · Series A Preferred Stock −92,509 0
2021-08-03 Feinberg Peter Director Conversion · Series A Preferred Stock −51,462 0
2021-08-03 Feinberg Peter Director Conversion · Series B Preferred Stock −30,646 0

Page 10 of 12 · 226 trades